{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T11:55:12Z","timestamp":1778241312793,"version":"3.51.4"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Travel Medicine and Infectious Disease"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.tmaid.2017.04.005","type":"journal-article","created":{"date-parts":[[2017,4,24]],"date-time":"2017-04-24T15:33:11Z","timestamp":1493047991000},"page":"5-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Prophylactic efficacy of primaquine for preventing Plasmodium falciparum and Plasmodium vivax parasitaemia in travelers: A\u00a0meta-analysis and systematic review"],"prefix":"10.1016","volume":"17","author":[{"given":"Goodarz","family":"Kolifarhood","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad","family":"Raeisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mansour","family":"Ranjbar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Akbar","family":"Haghdoust","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allan","family":"Schapira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeed","family":"Hashemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossein","family":"Masoumi-Asl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossein","family":"Mozafar Saadati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Azimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasim","family":"Khosravi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anatoly","family":"Kondrashin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9859","key":"10.1016\/j.tmaid.2017.04.005_bib1","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study","volume":"380","author":"Lozano","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.tmaid.2017.04.005_bib2","series-title":"Global technical strategy for malaria 2016-2030","author":"WHO","year":"2015"},{"key":"10.1016\/j.tmaid.2017.04.005_bib3","series-title":"World malaria report 2016","author":"WHO","year":"2016"},{"key":"10.1016\/j.tmaid.2017.04.005_bib4","series-title":"International travel and health: situation as on 1 January 2010","author":"WHO","year":"2010"},{"key":"10.1016\/j.tmaid.2017.04.005_bib5","series-title":"Tourism highlights","year":"2009"},{"key":"10.1016\/j.tmaid.2017.04.005_bib6","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1056\/NEJMoa021592","article-title":"Delayed onset of malaria\u2013implications for chemoprophylaxis in travelers","volume":"349","author":"Schwartz","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.tmaid.2017.04.005_bib7","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S1995-7645(11)60098-9","article-title":"Chemoprophylaxis in malaria; drugs, evidence of efficacy and costs","volume":"4","author":"Fernando","year":"2011","journal-title":"Asian Pac J Trop Med"},{"issue":"Suppl 3","key":"10.1016\/j.tmaid.2017.04.005_bib8","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/1475-2875-9-S3-S2","article-title":"Anti-malarial drugs and the prevention of malaria in the population of malaria endemic areas","volume":"9","author":"Greenwood","year":"2010","journal-title":"Malar J"},{"key":"10.1016\/j.tmaid.2017.04.005_bib9","first-page":"R137","article-title":"Guidelines for the prevention of malaria in travellers from the United Kingdom","volume":"7","author":"Bradley","year":"1997","journal-title":"Commun Dis Rep CDR Rev"},{"issue":"1466","key":"10.1016\/j.tmaid.2017.04.005_bib10","first-page":"52","article-title":"The medical letter on drugs and therapeutics","volume":"57","year":"2015","journal-title":"Advice Travel"},{"key":"10.1016\/j.tmaid.2017.04.005_bib11","series-title":"CDC health information for international travel, chapter 3: infectious Diseases related to travel, malaria 2016","author":"Centers for Disease Control and Prevention","year":"2016"},{"key":"10.1016\/j.tmaid.2017.04.005_bib12","series-title":"Canadian recommendations for the prevention and treatment of malaria","first-page":"135","author":"Public Health Agency of Canada","year":"2014"},{"issue":"1","key":"10.1016\/j.tmaid.2017.04.005_bib13","doi-asserted-by":"crossref","first-page":"e2012045","DOI":"10.4084\/mjhid.2012.045","article-title":"Prophylaxis of malaria","volume":"4","author":"Schwartz","year":"2012","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"20","key":"10.1016\/j.tmaid.2017.04.005_bib14","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1001\/jama.297.20.2251","article-title":"Controversies and misconceptions in malaria chemoprophylaxis for travelers","volume":"297","author":"Chen","year":"2007","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.tmaid.2017.04.005_bib15","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1586\/14787210.2.1.119","article-title":"Malaria chemoprophylaxis: when should we use it and what are the options?","volume":"2","author":"Petersen","year":"2004","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.tmaid.2017.04.005_bib16","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0002-9343(96)90011-X","article-title":"Malaria among United States troops in Somalia","volume":"100","author":"Wallace","year":"1996","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.tmaid.2017.04.005_bib17","doi-asserted-by":"crossref","first-page":"402","DOI":"10.4269\/ajtmh.2006.75.402","article-title":"Primaquine: report from CDC expert meeting on malaria chemoprophylaxis I","volume":"75","author":"Hill","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.tmaid.2017.04.005_bib18","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1086\/379714","article-title":"Primaquine for prevention of malaria in travelers","volume":"37","author":"Baird","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tmaid.2017.04.005_bib19","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.3390\/ph3103212","article-title":"Malaria prophylaxis: a comprehensive review","volume":"3","author":"Castelli","year":"2010","journal-title":"Pharmaceuticals"},{"issue":"6","key":"10.1016\/j.tmaid.2017.04.005_bib20","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.4269\/ajtmh.2011.11-0464","article-title":"Review: malaria chemoprophylaxis for travelers to Latin America","volume":"85","author":"Steinhardt","year":"2011","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.tmaid.2017.04.005_bib21","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1473-3099(12)70198-6","article-title":"Primaquine to prevent transmission of falciparum malaria","volume":"13","author":"White","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.tmaid.2017.04.005_bib22","series-title":"Single dose Primaquine as a gametocytocide in Plasmodium falciparum malaria","author":"WHO and Global Malaria Programme: Updated WHO Policy Recommendation","year":"2012"},{"key":"10.1016\/j.tmaid.2017.04.005_bib23","series-title":"WHO adverse reaction terminology (WHO-ART)","author":"Uppsala Monitoring Centre","year":"2001"},{"issue":"2","key":"10.1016\/j.tmaid.2017.04.005_bib24","doi-asserted-by":"crossref","first-page":"137","DOI":"10.4269\/ajtmh.1997.56.137","article-title":"Malaria in a nonimmune population after extended chloroquine or primaquine prophylaxis","volume":"56","author":"Fryauff","year":"1997","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.tmaid.2017.04.005_bib25","doi-asserted-by":"crossref","first-page":"707","DOI":"10.3346\/jkms.2005.20.5.707","article-title":"Evaluation of anti-malarial effects of mass chemoprophylaxis in the Republic of Korea army","volume":"20","author":"Yeom","year":"2005","journal-title":"J\u00a0Korean Med Sci"},{"key":"10.1016\/j.tmaid.2017.04.005_bib26","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1086\/313527","article-title":"Primaquine as prophylaxis for malaria for nonimmune travelers: a comparison with mefloquine and doxycycline","volume":"29","author":"Schwartz","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tmaid.2017.04.005_bib27","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/infdis\/171.6.1569","article-title":"daily primaquine is effective for prophylaxis against falciparum malaria in Kenya: comparison with mefloquine, doxycycline, and chloroquine plus proguanil","volume":"171","author":"Weiss","year":"1995","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.tmaid.2017.04.005_bib28","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/S0140-6736(95)92898-7","article-title":"Randomised placebo-controlled trial of primaquine for prophylaxis of falciparum and vivax malaria","author":"Fryauff","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.tmaid.2017.04.005_bib29","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0035-9203(02)90351-2","article-title":"Comparison of tafenoquine (WR238605) and primaquine in the post-exposure (terminal) prophylaxis of vivax malaria in Australian Defence Force personnel","volume":"96","author":"Nasveld","year":"2002","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.tmaid.2017.04.005_bib30","unstructured":"Soto J, Toledo J, Rodriquez M, Sanchez J, Herrera R, Padilla J. Primaquine Prophylaxis against Malaria in Nonimmune Colombian Soldiers: Efficacy and Toxicity. A randomized, Double-blind, placebo-controlled Trial."},{"issue":"6","key":"10.1016\/j.tmaid.2017.04.005_bib31","doi-asserted-by":"crossref","first-page":"479","DOI":"10.4269\/ajtmh.1995.52.479","article-title":"Primaquine for prophylaxis against malaria among nonimmune transmigrants in Irian Jaya","volume":"52","author":"Baird","year":"1995","journal-title":"Indones Am J Trop Med Hvg"},{"key":"10.1016\/j.tmaid.2017.04.005_bib32","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1086\/324085","article-title":"Randomized, parallel placebo-controlled trial of primaquine for malaria prophylaxis in Papua, Indonesia","volume":"33","author":"Baird","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tmaid.2017.04.005_bib33","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1086\/342578","article-title":"Randomized, placebo-controlled trial of atovaquone\/proguanil for the prevention of plasmodium falciparum or plasmodium vivax malaria among migrants to Papua, Indonesia","volume":"35","author":"Ling","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.tmaid.2017.04.005_bib34","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1517\/14740338.1.1.19","article-title":"Safety evaluation of the drugs available to prevent malaria","volume":"1","author":"Croft","year":"2002","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.tmaid.2017.04.005_bib35","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1086\/508782","article-title":"The practice of travel medicine: guidelines by the infectious Diseases society of America","volume":"43","author":"Hill","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.tmaid.2017.04.005_bib36","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1708-8305.1998.tb00473.x","article-title":"Imported severe falciparum malaria in Israel","volume":"5","author":"Weber","year":"1998","journal-title":"J\u00a0Travel Med"},{"key":"10.1016\/j.tmaid.2017.04.005_bib37","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1186\/1475-2875-13-481","article-title":"Severe vivax malaria: a systematic review and meta-analysis of clinical studies since 1900","volume":"13","author":"Rahimi","year":"2014","journal-title":"Malar J"},{"issue":"6","key":"10.1016\/j.tmaid.2017.04.005_bib38","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.1371\/journal.pmed.0050128","article-title":"Multidrug-resistant plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia","volume":"5","author":"Tjitra","year":"2008","journal-title":"PLoS Med"},{"key":"10.1016\/j.tmaid.2017.04.005_bib39","first-page":"391","article-title":"The antimalarial action of primaquine against blood stages of falciparum malaria (Panama P-F-6 strain)","volume":"46","author":"ArnoldA","year":"1955","journal-title":"J\u00a0Lab Clin Med"},{"key":"10.1016\/j.tmaid.2017.04.005_bib40","doi-asserted-by":"crossref","first-page":"243","DOI":"10.4269\/ajtmh.1996.55.243","article-title":"Primaquine resistance in Plasmodium vivax","volume":"55","author":"Collins","year":"1996","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.tmaid.2017.04.005_bib41","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1475-2875-13-51","article-title":"Mass primaquine treatment to eliminate vivax malaria: lessons from the past","volume":"13","author":"Kondrashin","year":"2014","journal-title":"Malar J"},{"issue":"11","key":"10.1016\/j.tmaid.2017.04.005_bib42","doi-asserted-by":"crossref","first-page":"e0004215","DOI":"10.1371\/journal.pntd.0004215","article-title":"Prevention of malaria resurgence in Greece through the association of mass drug administration (MDA) to immigrants from malaria-endemic regions and standard control measures","volume":"9","author":"Tseroni","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.tmaid.2017.04.005_bib43","series-title":"Guidelines for malaria prevention in travelers from the United Kingdom","first-page":"120","author":"Public Health England","year":"2016"},{"issue":"4","key":"10.1016\/j.tmaid.2017.04.005_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006491.pub2","article-title":"Drugs for preventing malaria in travellers","author":"Jacquerioz","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.tmaid.2017.04.005_bib45","doi-asserted-by":"crossref","first-page":"416","DOI":"10.4269\/ajtmh.2006.75.416","article-title":"Cost considerations of malaria chemoprophylaxis including use of primaquine for primary or terminal chemoprophylaxis","volume":"75","author":"Bryan","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.tmaid.2017.04.005_bib46","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12936-016-1140-x","article-title":"Cost-effectiveness analysis of rapid diagnostic tests for G6PD deficiency in patients with Plasmodium vivax malaria in the Brazilian Amazon","volume":"15","author":"Peixoto","year":"2016","journal-title":"Malar J"}],"container-title":["Travel Medicine and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893917300686?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893917300686?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:02:32Z","timestamp":1761487352000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1477893917300686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":46,"alternative-id":["S1477893917300686"],"URL":"https:\/\/doi.org\/10.1016\/j.tmaid.2017.04.005","relation":{},"ISSN":["1477-8939"],"issn-type":[{"value":"1477-8939","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prophylactic efficacy of primaquine for preventing Plasmodium falciparum and Plasmodium vivax parasitaemia in travelers: A\u00a0meta-analysis and systematic review","name":"articletitle","label":"Article Title"},{"value":"Travel Medicine and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmaid.2017.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}